Preview Mode Links will not work in preview mode

This Week in Cardiology

Feb 10, 2023

Drug and non-drug therapies for HFpEF, the search for AF, and exercise as medicine are the topics John Mandrola, MD, discusses in this week’s podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I. SGLT2 Inhibitors in HFpEF

Dapagliflozin Gets Expanded Heart Failure Indication in Europe

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

II. HFpEF and Heart Rate

Accelerated Pacing a Possible Strategy for Preserved-EF Heart Failure?

III. Stroke and AF

STROKE AF at 3 Years: High AF Rate After Atherosclerotic Stroke

  • Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease
  • Cryptogenic Stroke and Underlying Atrial Fibrillation
  • Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
  • Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

IV. Exercise as Medicine

Trending Clinical Topic: Exercise Prescription

  • Effect of Moderate and Vigorous Aerobic Exercise on Incident Diabetes in Adults With Obesity


Could a Breakthrough in Heart Failure With Preserved Ejection Fraction Just Take a Change of Pace?

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact